Paper30108856
Assessing the performance of docking scoring function, FEP, MM-GBSA, and QM/MM-GBSA approaches on a series of PLK1 inhibitors.
Pu C and 3 others. Medchemcomm, 2017. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Assessing the performance of docking scoring function, FEP, MM-GBSA, and QM/MM-GBSA approaches on a series of PLK1 inhibitors. Papers, record 30108856. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30108856
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Assessing the performance of docking scoring function, FEP, MM-GBSA, and QM/MM-GBSA approaches on a series of PLK1 inhibitors.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 18280498 | Rescoring docking hit lists for model cavity sites: predictions and experimental testing. | J Mol Biol | 2008 | https://conductscience.org/library/papers/18280498 | PubMed |
| 2 | 15766665 | ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent. | Cancer Cell | 2005 | https://conductscience.org/library/papers/15766665 | PubMed |
| 3 | 21545145 | Use of a QM/MM-based FEP method to evaluate the anomalous hydration behavior of simple alkyl amines and amides: application to the design of FBPase inhibitors for the treatment of type-2 diabetes. | J Am Chem Soc | 2011 | https://conductscience.org/library/papers/21545145 | PubMed |
| 4 | 23789789 | Assessing the performance of MM/PBSA and MM/GBSA methods. 3. The impact of force fields and ligand charge models. | J Phys Chem B | 2013 | https://conductscience.org/library/papers/23789789 | PubMed |
| 5 | 15350223 | Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells. | Mol Cell | 2004 | https://conductscience.org/library/papers/15350223 | PubMed |
| 6 | 12488480 | Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells. | J Natl Cancer Inst | 2002 | https://conductscience.org/library/papers/12488480 | PubMed |
| 7 | 15640844 | Polo-like kinases (Plks) and cancer. | Oncogene | 2005 | https://conductscience.org/library/papers/15640844 | PubMed |
| 8 | 8991084 | Antibody microinjection reveals an essential role for human polo-like kinase 1 (Plk1) in the functional maturation of mitotic centrosomes. | J Cell Biol | 1996 | https://conductscience.org/library/papers/8991084 | PubMed |
| 9 | 9126849 | Development and validation of a genetic algorithm for flexible docking. | J Mol Biol | 1997 | https://conductscience.org/library/papers/9126849 | PubMed |
| 10 | 15785925 | Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications. | Virchows Arch | 2005 | https://conductscience.org/library/papers/15785925 | PubMed |
| 11 | 27444142 | Assessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking. | Phys Chem Chem Phys | 2016 | https://conductscience.org/library/papers/27444142 | PubMed |
| 12 | 24683369 | Computing Clinically Relevant Binding Free Energies of HIV-1 Protease Inhibitors. | J Chem Theory Comput | 2014 | https://conductscience.org/library/papers/24683369 | PubMed |
| 13 | 15176053 | Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. | Prostate | 2004 | https://conductscience.org/library/papers/15176053 | PubMed |
| 14 | 22172702 | Identification of novel, potent and selective inhibitors of Polo-like kinase 1. | Bioorg Med Chem Lett | 2012 | https://conductscience.org/library/papers/22172702 | PubMed |
| 15 | 28144341 | Computational methods in drug discovery. | Beilstein J Org Chem | 2016 | https://conductscience.org/library/papers/28144341 | PubMed |
| 16 | 19125657 | Empirical scoring functions for advanced protein-ligand docking with PLANTS. | J Chem Inf Model | 2009 | https://conductscience.org/library/papers/19125657 | PubMed |
| 17 | 26216222 | Comparison of radii sets, entropy, QM methods, and sampling on MM-PBSA, MM-GBSA, and QM/MM-GBSA ligand binding energies of F. tularensis enoyl-ACP reductase (FabI). | J Comput Chem | 2015 | https://conductscience.org/library/papers/26216222 | PubMed |
| 18 | 26592101 | Improving the Prediction of Absolute Solvation Free Energies Using the Next Generation OPLS Force Field. | J Chem Theory Comput | 2012 | https://conductscience.org/library/papers/26592101 | PubMed |
| 19 | 25205360 | Assessing the performance of MM/PBSA and MM/GBSA methods. 5. Improved docking performance using high solute dielectric constant MM/GBSA and MM/PBSA rescoring. | Phys Chem Chem Phys | 2014 | https://conductscience.org/library/papers/25205360 | PubMed |
| 20 | 18929484 | Imidazo[5,1-f][1,2,4]triazin-2-amines as novel inhibitors of polo-like kinase 1. | Bioorg Med Chem Lett | 2008 | https://conductscience.org/library/papers/18929484 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41774209 | Computer-aided drug design in acute myeloid leukemia: a comprehensive review of advances, challenges, and future prospect. | J Comput Aided Mol Des | 2026 | https://conductscience.org/library/papers/41774209 | PubMed |
| 40723870 | Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723870 | PubMed |
| 39339280 | Novel Autotaxin Inhibitor ATX-1d Significantly Enhances Potency of Paclitaxel-An In Silico and In Vitro Study. | Molecules | 2024 | https://conductscience.org/library/papers/39339280 | PubMed |
| 38650742 | Bioactive compounds from Morchella esculenta as potential inhibitors of RNA-binding protein La in ovarian cancer: a molecular modeling and quantum mechanics approach. | In Silico Pharmacol | 2024 | https://conductscience.org/library/papers/38650742 | PubMed |
| 37529282 | Modelling peptide-protein complexes: docking, simulations and machine learning. | QRB Discov | 2022 | https://conductscience.org/library/papers/37529282 | PubMed |
| 37241849 | Binding and Dynamics Demonstrate the Destabilization of Ligand Binding for the S688Y Mutation in the NMDA Receptor GluN1 Subunit. | Molecules | 2023 | https://conductscience.org/library/papers/37241849 | PubMed |
| 36988562 | Structure Determination of Challenging Protein-Peptide Complexes Combining NMR Chemical Shift Data and Molecular Dynamics Simulations. | J Chem Inf Model | 2023 | https://conductscience.org/library/papers/36988562 | PubMed |
| 36615367 | Comprehensive Survey of Consensus Docking for High-Throughput Virtual Screening. | Molecules | 2022 | https://conductscience.org/library/papers/36615367 | PubMed |
| 35930206 | Modeling receptor flexibility in the structure-based design of KRASG12C inhibitors. | J Comput Aided Mol Des | 2022 | https://conductscience.org/library/papers/35930206 | PubMed |
| 35720345 | Computational Structure Prediction for Antibody-Antigen Complexes From Hydrogen-Deuterium Exchange Mass Spectrometry: Challenges and Outlook. | Front Immunol | 2022 | https://conductscience.org/library/papers/35720345 | PubMed |
| 35629327 | Computational Investigations on the Natural Small Molecule as an Inhibitor of Programmed Death Ligand 1 for Cancer Immunotherapy. | Life (Basel) | 2022 | https://conductscience.org/library/papers/35629327 | PubMed |
| 35039800 | Molecular docking-based computational platform for high-throughput virtual screening. | CCF Trans High Perform Comput | 2022 | https://conductscience.org/library/papers/35039800 | PubMed |
| 32340232 | Application of MM-PBSA Methods in Virtual Screening. | Molecules | 2020 | https://conductscience.org/library/papers/32340232 | PubMed |
| 32201802 | graphDelta: MPNN Scoring Function for the Affinity Prediction of Protein-Ligand Complexes. | ACS Omega | 2020 | https://conductscience.org/library/papers/32201802 | PubMed |
| 31956784 | Insights into the Binding Recognition and Susceptibility of Tofacitinib toward Janus Kinases. | ACS Omega | 2020 | https://conductscience.org/library/papers/31956784 | PubMed |
| 31487867 | Molecular Docking: Shifting Paradigms in Drug Discovery. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/31487867 | PubMed |
| 31355188 | Refinement and Rescoring of Virtual Screening Results. | Front Chem | 2019 | https://conductscience.org/library/papers/31355188 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PLK1 | 5347 | PubTator's text mining | https://conductscience.org/library/genes/5347 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30108856
GET https://conductscience.org/api/papers/v1/30108856/references?page=2